Swab-based pepsin activity results in minutes Giving clinicians helpful data for reflux evaluation

Veritas-DX is developing pepPOP™, a prescription, clinician-used, single-use qualitative color-change test designed to show evidence of pepsin activity in minutes. Pepsin is a stomach digestive enzyme that clinicians may interpret when evaluating reflux.

  • Results in minutes
  • No lab or electronics
  • Qualitative color-change readout
  • Class II 510(k) path in preparation

Regulatory status: pepPOP™ is an investigational prescription device. It is not FDA cleared or approved, is not available for sale, and is intended to test for pepsin for clinician interpretation in reflux evaluation, not to diagnose acid reflux or GERD as a standalone test.

pepPOP single-use color-change pepsin activity test kit
pepPOP™ — investigational single-use color-change pepsin activity test in development.
Rx
Prescription only
Less than 20%
patients ever tested
$2.1B
U.S. serviceable market
Results in minutes
point-of-care workflow
The Innovation

We don't just detect pepsin. We detect pepsin activity.

Sample

Simple cheek swab sample

No invasive, uncomfortable, slow lab-based workflow.

Chemistry

Add and observe

Two-stage pepsin steps to better understand activity.

Readout

Visible color-change result in minutes

The presence or absence of a colorimetric change during the two-stage test gives the clinician data to better recommend reflux therapy.

Head to Head

Simply a faster, more comfortable, more useful point-of-care test

How pepPOP™ compares to other tools clinicians may use when evaluating reflux.

pepPOP™Veritas-DX Mail-in pepsin testPepsinCheck® / Peptest® Ambulatory pH probeBravo / catheter
Where it's doneBy a clinician at the visitSample mailed to a labSpecialist clinic
Result inMinutes~A weekAfter 24–96 hrs of wear
Time burdenDesigned for clinician use during a single visitSample collection, shipping, and lab turnaroundDevice placement, wear period, return, and interpretation
Cost profileSingle-use qualitative test; no lab or electronicsLab processing and logistics modelSpecialist equipment, procedure, and monitoring workflow
What it providesQualitative pepsin activity evidence based on visible color changePepsin presence — yes / noAcid exposure data
Where it's readVisual color change on the single-use testLab instrumentCapsule / catheter recorder
FDA statusClass II 510(k) strategy in preparation; not clearedClass 1 listing510(k) cleared
The Opportunity

We are reinventing the standard of care for acid reflux testing

We believe pepPOP™ can help change the standard of care by giving clinicians a useful, fast point-of-care tool for pepsin activity evidence once FDA cleared for commercial distribution.

$2.1B
U.S. serviceable market
  • Regulatory pathClass II 510(k)
  • StatusWorking prototype · FDA Pre-Sub scheduled · Non-provisional filings · Supply chain development
  • ModelSwab-based qualitative test with results in minutes
Leadership

Experienced Leadership

Joetta Stewart headshot

Joetta Stewart, DDS

Co-Founder & CEO

Practicing dentist and Air Force veteran who discovered the clinical gap, invented the detection approach, and prototyped the technology.

Richard Thompson headshot

Richard Thompson

Co-Founder & CTO

26+ year product development expert and serial founder who has helped bring 25+ products to market and 24+ patents and founder of Sailfish Labs.

AJ

Adam Johnson

Quality & Regulatory Advisor

24+ years helping companies successfully navigate FDA regulatory and quality processes during development, launch, and production for startups, mid-size companies, and international organizations.

Investor Relations

Join us in building Veritas-DX

We're raising to advance pepPOP™ through development, regulatory preparation, and FDA review. Detailed materials are shared with verified accredited investors.

  • Focused category position. Prescription clinician-used testing built around qualitative pepsin activity evidence, not symptoms alone.
  • Regulatory discipline. Professional-use Class II 510(k) strategy in preparation before any commercial distribution.
  • Simple single-use model. A qualitative color-change test designed for use without lab processing or electronics, subject to clearance and commercialization.

For information only; not an offer to sell or solicitation to buy any security. Any offer is made solely to verified accredited investors via definitive documents under applicable securities laws.